Pentasa 500 mg prolonged - release tablets
Country: Bulgarija
Lingwa: Bulgaru
Sors: Изпълнителна агенция по лекарствата
Fuljett ta 'informazzjoni
(PIL)
06-03-2023
Karatteristiċi tal-prodott
(SPC)
06-03-2023
Ingredjent attiv:
Месалазин
Disponibbli minn:
Ferring GmbH
Kodiċi ATC:
A07EC2
INN (Isem Internazzjonali):
Mesalazine
Dożaġġ:
500 mg prolonged - release tablets
Sommarju tal-prodott:
Pentasa, 500 mg prolonged-release tablets x 100
Data ta 'l-awtorizzazzjoni:
2014-10-13
